Equity Analysis /
United States of America

US : UnitedHealth Group Incorporated - UNH | First Take: 4Q20 Results Top Guidance; COVID Costs and Rebates Weigh on UHC Profits

    Alex Ruscher
    Alex Ruscher

    Sr. Res. Assoc.

    Follow
    CGS-CIMB
    20 January 2021
    Published byCGS-CIMB

    4Q20 results top guidance and Street expectations while management maintains 2021 outlook given at the December Investor Day.Revenues (+): $65.5B up 7.5% y/y (Street: $64.9B; RJe: $64.9B). UHC : $50.33B +4.2% y/y (RJe: $50.97B).Optum: $35.85B +20.3% y/y (RJe: $35.38B)EBIT (+): $3.52B down -31% y/y